Am J Respir Crit Care Med. 2020 May 15;201(10):1182-1192. doi: 10.1164/rccm.202003-0512ST.
: ICU clinicians regularly care for patients who lack capacity, an applicable advance directive, and an available surrogate decision-maker. Although there is no consensus on terminology, we refer to these patients as "unrepresented." There is considerable controversy about how to make treatment decisions for these patients, and there is significant variability in both law and clinical practice.: This multisociety statement provides clinicians and hospital administrators with recommendations for decision-making on behalf of unrepresented patients in the critical care setting.: An interprofessional, multidisciplinary expert committee developed this policy statement by using an iterative consensus process with a diverse working group representing critical care medicine, palliative care, pediatric medicine, nursing, social work, gerontology, geriatrics, patient advocacy, bioethics, philosophy, elder law, and health law.: The committee designed its policy recommendations to promote five ethical goals: ) to protect highly vulnerable patients, ) to demonstrate respect for persons, ) to provide appropriate medical care, ) to safeguard against unacceptable discrimination, and ) to avoid undue influence of competing obligations and conflicting interests. These recommendations also are intended to strike an appropriate balance between excessive and insufficient procedural safeguards. The committee makes the following recommendations: ) institutions should offer advance care planning to prevent patients at high risk for becoming unrepresented from meeting this definition; ) institutions should implement strategies to determine whether seemingly unrepresented patients are actually unrepresented, including careful capacity assessments and diligent searches for potential surrogates; ) institutions should manage decision-making for unrepresented patients using input from a diverse interprofessional, multidisciplinary committee rather than by treating clinicians; ) institutions should use all available information on the patient's preferences and values to guide treatment decisions; ) institutions should manage decision-making for unrepresented patients using a fair process that comports with procedural due process; ) institutions should employ this fair process even when state law authorizes procedures with less oversight.: This multisociety statement provides guidance for clinicians and hospital administrators on medical decision-making for unrepresented patients in the critical care setting.
: ICU 临床医生经常照顾那些没有能力、适用的预先指示和可用替代决策人的患者。尽管在术语上没有共识,但我们称这些患者为“未代表”。对于如何为这些患者做出治疗决策存在相当大的争议,法律和临床实践都存在很大的差异。: 本多学会声明为重症监护环境中的代表患者提供了临床医生和医院管理人员的决策建议。: 一个跨专业、多学科的专家委员会通过使用代表重症监护医学、姑息治疗、儿科医学、护理、社会工作、老年学、老年医学、患者权益、生物伦理学、哲学、老年法和健康法的多样化工作组,使用迭代共识过程制定了这项政策声明。: 委员会设计其政策建议旨在促进五个道德目标:) 保护高度脆弱的患者,) 表现出对人的尊重,) 提供适当的医疗护理,) 防止不可接受的歧视,) 避免竞争义务和利益冲突的不当影响。这些建议还旨在在过度和不足的程序保障之间取得适当的平衡。委员会提出以下建议:) 机构应提供预先护理计划,以防止有成为未代表患者风险的患者符合这一定义;) 机构应实施策略来确定看似未代表的患者是否实际上未代表,包括仔细进行能力评估和仔细寻找潜在的代理人;) 机构应使用来自多样化的跨专业、多学科委员会的输入来管理未代表患者的决策,而不是由治疗临床医生来管理;) 机构应使用患者偏好和价值观的所有可用信息来指导治疗决策;) 机构应使用符合程序正当程序的公平流程来管理未代表患者的决策;) 即使州法律授权程序监管较少,机构也应采用此公平流程。: 本多学会声明为重症监护环境中的代表患者提供了临床医生和医院管理人员的决策建议。